A detailed history of Burney CO transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Burney CO holds 11,121 shares of LGND stock, worth $1.24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,121
Previous 3,471 220.4%
Holding current value
$1.24 Million
Previous $292,000 281.16%
% of portfolio
0.04%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$82.7 - $110.11 $632,655 - $842,341
7,650 Added 220.4%
11,121 $1.11 Million
Q2 2024

Jul 29, 2024

SELL
$68.53 - $87.91 $3,632 - $4,659
-53 Reduced 1.5%
3,471 $292,000
Q1 2024

May 22, 2024

BUY
$68.64 - $89.2 $28,554 - $37,107
416 Added 13.38%
3,524 $257,000
Q4 2023

Feb 12, 2024

BUY
$49.57 - $72.63 $154,063 - $225,734
3,108 New
3,108 $221,000
Q2 2023

Aug 09, 2023

BUY
$69.53 - $79.33 $3.62 Million - $4.13 Million
52,030 New
52,030 $3.75 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Burney CO Portfolio

Follow Burney CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.